De aprobarse, Litfulo® sería el único tratamiento autorizado en la UE para tratar la alopecia areata grave en pacientes mayores de 12 años.
Artículos relacionados
[Translated article] Chemotherapy, Alopecia, and Scalp Cooling Systems
diciembre 27, 2022
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 113. Núm. 3. (Marzo 2022)
Chemotherapy-induced hair loss in cancer is usually temporary but can take a significant emotional toll on patients and lead to treatment refusal in many cases. Although hair loss is usually reversible, regrowth can take months, […]
[Translated article] Trichoscopy: An Update
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 4. (Abril 2023)
Trichoscopy is a simple, noninvasive office procedure that can be performed using a handheld or digital dermatoscope. This tool has gained popularity in recent years, because it provides useful diagnostic information for hair loss and […]
[Translated article] Histopathologic and Trichoscopic Correlations in Nonscarring Alopecias
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 6. (Junio 2023)
Trichoscopy is an essential tool in the evaluation of alopecia. The current compilation of trichoscopic signs in this setting helps distinguish between different forms of hair loss and has improved our understanding of the pathogenic […]